業績

20202019201820172016201520142013201220112010

カテゴリー別
 

2021

(論文)

Hayashi T, Nakashima Y, Nishimoto M, Nanno S, Naka R, Gyobu K, Lee S, Okamoto S, Hino M, Nakamae H.
 
High-Dose Chemotherapy With Autologous Stem Cell Transplantation in a Case of Refractory Peripheral T Cell Lymphoma With Tracheoesophageal Fistula: A Case Report

Transplant Proc. 2021 Dec

Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, Hashii Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y; on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group.
 
Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation

Am J Hematol. 2021 Nov 5

Akahoshi Y, Kimura SI, Tada Y, Matsukawa T, Tamaki M, Doki N, Uchida N, Tanaka M, Nakamae H, Kuriyama T, Matsuoka KI, Ikeda T, Kimura T, Fukuda T, Kanda Y, Atsuta Y, Murata M, Terakura S, Nakasone H.
 
Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease

Blood Adv. 2021 Nov 17:bloodadvances.2021005885

Takakuwa T, Nakagama Y, Yasugi M, Maeda T, Matsuo K, Kiritoshi A, Deguchi R, Hagawa N, Shibata W, Oshima K, Yamamoto K, Uchida K, Noda T, Yamada K, Nishimura T, Yamamoto H, Kido Y, Hino M, Kakeya H, Mizobata Y.
 
Discrepant Antigen-specific Antibody Responses Causing SARS-CoV-2 Persistence in a Patient Receiving B-cell-targeted Therapy with Rituximab

Intern Med. 2021;60(23):3827-3831

Nakamae M, Nakamae H, Hashimoto M, Koh H, Nakashima Y, Hirose A, Hino M .
 
Predictive value of clinical examination parameters for cardiovascular adverse events during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors

Int J Hematol. 2021 Nov 17.

Inoue T, Koyama M, Kaida K, Ikegame K, Ensbey KS, Samson L, Takahashi S, Zhang P, Minnie SA, Maruyama S, Ishii S, Daimon T, Fukuda T, Nakamae H, Ara T, Maruyama Y, Ishiyama K, Ichinohe T, Atsuta Y, Blazar BR, Furlan SN, Ogawa H, Hill GR..
 
Peritransplant glucocorticoids redistribute donor T cells to the bone marrow and prevent relapse after haploidentical SCT

JCI Insight. 2021 Nov 22;6(22):e153551.

Nakako S, Nakashima Y, Okamura H, Tani Y, Ueda T, Makuuchi Y, Kuno M, Takakuwa T, Nishimoto M, Koh H, Nakamae H, Hino M. .
 
Delayed immune-related neutropenia with hepatitis by pembrolizumab

Immunotherapy. 2021 Nov 11

Nakamae H, Nakane T, Okamura H, Koh H, Nakashima Y, Hirose A, Nakamae M, Nishimoto M, Kuno M, Makuuchi Y, Harada N, Takakuwa T, Hino M.
 
A phase II study of post?transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA?matched related/unrelated allogeneic hematopoietic stem cell transplantation

Int J Hematol. 2021 Nov 1

Takakuwa T, Ohta K, Sogabe N, Nishimoto M, Kuno M, Makuuchi Y, Okamura H, Nakashima Y, Koh H, Nakamae H, Hino M. .
 
Isatuximab plus Pomalidomide and Dexamethasone in a Patient with Dialysis-Dependent Multiple Myeloma

Chemotherapy. 2021;66(5-6):192-195

Kobayashi S, Kanda Y, Konuma T, Inamoto Y, Matsumoto K, Uchida N, Ikegame K, Miyamoto T, Doki N, Nakamae H, Katayama Y, Takahashi S, Shiratori S, Saito S, Kawakita T, Kanda J, Fukuda T, Atsuta Y, Kimura F....
 
Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation

Bone Marrow Transplant. 2021 Oct 8.

Nakamae H, Yamamoto M, Sakaida E, Kanda Y, Ohmine K, Ono T, Matsumura I, Ishikawa M, Aoki M, Maki A, Shibayama H...
 
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow?up of the Japanese subgroup of the randomized ENESTnd trial

Int J Hematol. 2021 Sep 11.

Ito A, Nakano N, Tanaka T, Fuji S, Makiyama J, Inoue Y, Choi I, Nakamae H, Nagafuji K, Takase K, Machida S, Takahashi T, Sawayama Y, Kamimura T, Kato K, Kawakita T, Ogata M, Sakai R, Shiratori S, Uchimaru K, Inamoto Y, Utsunomiya A, Fukuda T...
 
Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study

Blood Adv. 2021 Oct 26;5(20):4156-4166..

Ido K, Koh H, Hirose A, Seto T, Makuuchi Y, Kuno M, Takakuwa T, Okamura H, Nanno S, Nakamae M, Nishimoto M, Nakashima Y, Hino M, Nakamae H..
 
Effect of Donor NKG2D Polymorphism on Relapse after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Transplant Cell Ther. 2021 Oct 1:S2666-6367(21)01261-6.

Yanada M, Konuma T, Yamasaki S, Harada K, Iwasaki M, Kobayashi A, Nishijima A, Tanaka M, Uchida N, Nakamae H, Fukuda T, Onizuka M, Ozawa Y, Sawa M, Katayama Y, Yoshioka S, Kimura T, Ichinohe T, Atsuta Y, Kanda J, Yano S. .
 
Allogeneic Hematopoietic Cell Transplantation from Alternative Donors in Acute Myelogenous Leukemia: A Comparative Analysis

Transplant Cell Ther. 2021 Sep 6:S2666-6367(21)01218-5

Kimura SI, Tamaki M, Okinaka K, Seo S, Uchida N, Igarashi A, Ozawa Y, Ikegame K, Eto T, Tanaka M, Shiratori S, Nakamae H, Sawa M, Kawakita T, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Nakasone H.. .
 
Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group

Ann Hematol. 2021 Dec;100(12):3029-3038

Fuji S, Hakoda A, Kanda J, Murata M, Terakura S, Inamoto Y, Uchida N, Toya T, Eto T, Nakamae H, Ikegame K, Tanaka M, Kawakita T, Kondo T, Miyamoto T, Fukuda T, Ichinohe T, Kimura T, Atsuta Y, Shintani A, Morishima S. .
 
Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes

Bone Marrow Transplant. 2021 Dec;56(12):2990-2996

Yanada M, Mizuno S, Yamasaki S, Harada K, Konuma T, Tamaki H, Shingai N, Uchida N, Ozawa Y, Tanaka M, Onizuka M, Sawa M, Nakamae H, Shiratori S, Matsuoka KI, Eto T, Kawakita T, Maruyama Y, Ichinohe T, Kanda Y, Atsuta Y, Aoki J, Yano .
 
Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes

Leuk Lymphoma. 2021 Aug 4:1-9

Harada N, Tagami M, Koh H, Ohsawa M, Hino M, Nakamae H. .
 
Tiny transformed diffuse large B cell lymphoma localized to the left conjunctiva

Int J Hematol. 2021 Aug 23.

Okamura H, Nakamae H, Shindo T, Ohtani K, Hidaka Y, Ohtsuka Y, Makuuchi Y, Kuno M, Takakuwa T, Harada N, Nishimoto M, Nakashima Y, Koh H, Hirose A, Nakamae M, Wakamiya N, Hino M, Inoue N. .
 
Early Elevation of Complement Factor Ba Is a Predictive Biomarker for Transplant-Associated Thrombotic Microangiopathy

Front Immunol. 2021 Jul 13;12:695037

Hayashi T, Nakamae H, Takeda S, Nakashima Y, Koh H, Nishimoto M, Okamura H, Nanno S, Makuuchi Y, Kuno M, Nakamae M, Hirose A, Hino M. .
 
Increasing numbers of CD19 + CD24 high CD38 high regulatory B cells and pre-germinal center B cells reflect activated autoimmunity and predict future treatment response in patients with untreated immune thrombocytopenia

Int J Hematol. 2021 Jul 26

Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T, Henzan H, Takase K, Yamasaki S, Makiyama J, Moriuchi Y, Choi I, Nakano N, Hiramoto N, Kato K, Sato T, Sawayama Y, Kim SW, Inoue Y, Inamoto Y, Fukuda T.
 
A phase I/II multicenter trial of HLA-haploidentical PBSCT with PTCY for aggressive adult T-cell leukemia/lymphoma

Transplant Cell Ther. 2021 Jul 15:S2666-6367(21)01075-7

Nakako S, Takakuwa T, Ichimura H, Okamura H, Nanno S, Nishimoto M, Nakashima Y, Koh H, Hino M, Nakamae H.. .
 
Successful management of therapy-related chronic myelomonocytic leukemia with cytarabine, aclarubicin, and azacitidine following tegafur/gimeracil/oteracil

Clin Case Rep. 2021 Jun 24;9(6):e04298

Nakamura M, Arai Y, Hirabayashi S, Kondo T, Doki N, Uchida N, Fukuda T, Ozawa Y, Tanaka M, Sawa M, Katayama Y, Kanda Y, Shiratori S, Nakamae H, Yoshioka S, Onizuka M, Ichinohe T, Atsuta Y, Kako S... .
 
Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation

Br J Haematol. 2021 Jul;194(2):403-413

岡村浩史、中前博久
 
骨髄移植後TMAとaHUS

Thrombosis Medicine 2021,11(3)227-231

仲子聡一郎、白神大志、橋村光晴、市原弘善、麦谷安津子
 
カルフィルゾミブによる腸管喪失型低マグネシウム血症

臨床血液 2021,62(3)190-192

南野 智、中前博久
 
TKI時代におけるPh陽性急性リンパ芽球性
白血病の化学療法の動向

血液内科 2021,62(4)454-460

康 秀男、日野雅之
 
赤白血病におけるマスター転写因子のドライバー変異

血液内科 2021,62(5)704-710

Kuwabara G, Tazoe K, Imoto W, Yamairi K, Shibata W, Oshima K, Yamada K, Takagi Y, Shiraishi S, Hino M, Kawaguchi T, Kakeya H. .
 
A Case of Isoniazid-induced Immune Thrombocytopenia

Intern Med. 2021 May 29

Koh S, Koh H, Nanno S, Okamura H, Nakashima Y, Nakamae M, Hirose A, Hino M, Nakamae H. .
 
Kinetics of IgG subclasses and their effects on the incidence of infection after allogeneic hematopoietic stem cell transplantation

Transpl Immunol. 2021 May 20;67:101413

Hosen N, Yoshihara S, Takamatsu H, Ri M, Nagata Y, Kosugi H, Shimomura Y, Hanamura I, Fuji S, Minauchi K, Kuroda J, Suzuki R, Nishimura N, Uoshima N, Nakamae H, Kawano Y, Mizuno I, Gomyo H, Suzuki K, Ozaki S, Nakamura S, Imai Y, Kizaki M, Negoro E, Handa H, Iida S.. .
 
Expression of activated integrin β7 in multiple myeloma patients

Int J Hematol. 2021 May 17

Shimomura Y, Hara M, Konuma T, Itonaga H, Doki N, Ozawa Y, Eto T, Uchida N, Aoki J, Kato J, Onishi Y, Takahashi S, Fukushima K, Nakamae H, Kawakita T, Tanaka J, Fukuda T, Atsuta Y, Ishikawa T, Ishiyama K.. .
 
Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome in adolescent and young adult patients

Bone Marrow Transplant. 2021 May 15

Tanizawa N, Koh H, Okamura H, Yamamoto K, Makuuchi Y, Kuno M, Takakuwa T, Koh S, Nanno S, Nishimoto M, Hirose A, Nakamae M, Nakashima Y, Nakane T, Hino M, Nakamae H. .
 
Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation.

Transplant Cell Ther. 2021 May;27(5):437.e1-437.e9.

Nanno S, Koh H, Okamura H, Nishimoto M, Nakashima Y, Ohsawa M, Hino M, Nakamae H.
 
Acute fibrinous and organizing pneumonia following hemophagocytic syndrome in two adult patients with hematological malignancies.

J Clin Exp Hematop. 2021 Apr 20.

Konuma T, Kanda J, Yamasaki S, Harada K, Shimomura Y, Terakura S, Mizuno S, Uchida N, Tanaka M, Doki N, Ozawa Y, Nakamae H, Sawa M, Matsuoka KI, Morishige S, Maruyama Y, Ikegame K, Kimura T, Kanda Y, Ichinohe T, Atsuta Y, Yanada M.
 
Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete Remission.

Transplant Cell Ther. 2021 Apr;27(4):334.e1-334.e11

Terakura S, Kuwatsuka Y, Sugita J, Takahashi S, Ozawa Y, Ozeki K, Yoshioka S, Nakamae H, Kawakita T, Sawa M, Morishige S, Najima Y, Katsuoka Y, Sakaida E, Kouzai Y, Kimura T, Ichinohe T, Fukuda T, Atsuta Y, Murata M, Teshima T.
 
Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia

Int J Hematol. 2021 Feb 21..

Takakuwa T, Ohta K, Nakatani E, Ito T, Kaneko H, Fuchida SI, Shimura Y, Yagi H, Shibayama H, Kanda J, Uchiyama H, Kosugi S, Tanaka H, Kawata E, Uoshima N, Ishikawa J, Shibano M, Karasuno T, Shindo M, Shimizu Y, Imada K, Kanakura Y, Kuroda J, Hino M, Nomura S, Takaori-Kondo A, Shimazaki C, Matsumura I.
 
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma

Hematol Oncol. 2021 Mar 16.

Harada N, Okamura H, Nakane T, Koh S, Nanno S, Nishimoto M, Hirose A, Nakamae M, Nakashima Y, Koh H, Hino M, Nakamae H.
 
Pretransplant plasma brain natriuretic peptide and N-terminal probrain natriuretic peptide are more useful prognostic markers of overall survival after allogeneic hematopoietic cell transplantation than echocardiography

Bone Marrow Transplant. 2021 Feb 1

Takakuwa T, Yamamura R, Ohta K, Kaneko H, Imada K, Nakaya A, Fuchida SI, Shibayama H, Matsuda M, Shimazu Y, Adachi Y, Kosugi S, Uchiyama H, Tanaka H, Hanamoto H, Shimura Y, Kanda J, Onda Y, Uoshima N, Yagi H, Yoshihara S, Hino M, Shimazaki C, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S.
 
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis

Eur J Haematol. 2021 Jan 21.

Nakano N, Utsunomiya A, Matsuo K, Yoshida N, Seto M, Ohshima K, Fujiwara H, Fuji S, Takatsuka Y, Ito A, Miyamoto T, Suehiro Y, Nakamae H, Sawayama Y, Yuasa M, Miyazaki Y, Ota S, Imada K, Fukuda T, Ichinohe T, Atsuta Y, Kato K.
 
Chromosomal defects and survival in patients with adult T-cell leukemia/lymphoma after allogeneic HSCT

Blood Adv. 2021 Jan 26;5(2):475-486

曽我部信広、三住拓誉、川瀬太助、奥 比呂志、則本和伸、嶋岡英輝
 
短期間に遭遇した後天性血友病Aの2症例

臨床麻酔 2021,45(2),173-177

中前博久
 
移植後シクロホスファミドを用いたHLAハプロ一致同種造血幹細胞移植における今後の戦略

日本造血細胞移植学会雑誌 2021,10(1),48-57

 

(学会)

 

234回内科学会近畿地方会
WEB 12月4日
急性前骨髄球性白血病の寛解導入療法中に分化症候群の一つとして急性膵炎を発症した1例
枡谷彩耶,仲子聡一郎,幕内陽介,久野雅智,高桑輝人,西本光孝,中嶋康博,康 秀男,中 前博久,日野雅之
抗真菌薬併用により化学療法を継続し得た悪性リンパ腫に合併したクリプトコッカス髄膜炎
八重秀克,白神大志,川添麻衣,森口 慎,麥谷安津子

 

116回近畿血液学地方会
WEB 11月27日
39
成熟B細胞性腫瘍の経過観察中にCOVID-19ワクチンを接種し、自己免疫性溶血性貧血を発症した症例
曽我部信広、久野雅智、幕内陽介、高桑輝人、岡村浩史、西本光孝、中嶋康博、康 秀男、中前博久、日野雅之
38
COVID−19感染により急性白血病様の骨髄所見を呈した1例
木村友美、林 良樹、大山利栄、芦田郷夢、清水克純、八木尚子、吉田全宏、吉村卓朗、中尾隆文、山根孝久
9
強力な寛解導入療法不応の骨髄/NK前駆細胞性急性白血病に対してAzacitidine/Venetoclax療法が奏効した一例
塩見一郎、、中根孝彦、藤谷 洋太朗、荒木 拓、小川優美、乙丸一平、山村亮介、曽我文隆、福島有星
62
正常経腟分娩可能であったフォン・ヴィレブランド病の1令
川添麻衣、八重秀克、森口 慎、白神弘和、麦谷安津子

 

68回日本臨床検査医学会
WEB 11月11日-14日
S2-1
臨床検査室にようこそ!
井戸健太郎
P-160
チロシンキナーゼ阻害剤治療注慢性骨髄性白血病の心血管有害事象に対する臨床検査パラメータによる予測
中前美佳、中前博久、橋本深香、廣瀬朝生、中嶋康博、久保田 浩、日野雅之

 

83回日本血液学会総会
WEB 9月23日・25日
OS1-9D-1
Very elderly patients with myeloma: a multicenter retrospective analysis from Kansai Myeloma Forum
Yusuke Okayama,Teruhito Takakuwa,Yuji Shimura,Hitomi Kaneko,Kazunori Imada,Satoru Kosugi,Tomoki Ito,Shinichi Fuchida,Hirokazu Tanaka,Nobuhiko Uoshima,Satoshi Yoshihara,Junya Kanda,Hirohiko Shibayama,Kentaro Fukushima,Kensuke Ohta,Hideo Yagi,Shosaku Nomura,Chihiro Shimazaki,Itaru Matsumura,Akifumi Takaori-Kondo,Naoki Hosen,Masayuki Hino,Junya Kuroda
OS1-9D-2
Novel web application predicting patient-specific prognosis in MM from KMF using machine learning
Teruhito Takakuwa,Hiroshi Okamura,Yutaka Shimazu,Hitomi Kaneko,Kazunori Imada,Tomoki Ito,Ryosuke Yamamura,Kensuke Ohta,Satoru Kosugi,Hirokazu Tanaka,Shinichi Fuchida,Yuji Shimura,Junya Kanda,Nobuhiko Uoshima,Hirohiko Shibayama,Satoshi Yoshihara,Hideo Yagi,Masayuki Hino,Yuzuru Kanakura,Junya Kuroda,Akifumi Takaori-Kondo,Chihiro Shimazaki,Itaru Matsumura,Shosaku Nomura
OS3-13B-3
Retrospective case series of hematological patients with SARS-CoV-2 infection in our hospita
Takahiko Nakane,Tetsuya Ueda,Masanori Azuma,Yoshimune Miyazaki,Ryuichi Saito,Yusuke Kusakabe,Kazuki Ohta,Akiko Miura,Yotaro Fujitani,Tadayoshi Sado,Yusei Fukushima,Manabi Nakamura,Ryuichi Sato,Yuki Haruta,Ichiro Shiomi,Mirei Horiuchi,Taku Araki,Ippei Otomaru,Yumi Tagaito,Katsuzumi Shimizu,Yoshiyuki Miki,Atsuko Horikoshi,Naoko Kawaguchi,Mayumi Inamura,Ryosuke Yamamura,Yoshinori Hasegawa,Yoshinori Yasui

OS3-9C-1
Salvage therapy with pralatrexate and romidepsin followed by autologous PBSCT for relapsed SPTCL
Daiki Mukai,Masatomo Kuno,Kentaro Ido,Yosuke Makuuchi,Teruhito Takakuwa,Hiroshi Okamura,Satoru Nanno,Asao Hirose,Mika Nakamae,Mitsutaka Nishimoto,Yasuhiro Nakashima,Hideo Koh,Hirohisa Nakamae,Masayuki Hino

PS-38-4
A case of rapid multi-organ failure with amyloidosis that progressed from MGUS to multiple myeloma
Kumiyo Tazoe,Teruhito Takakuwa,Yosuke Makuuchi,Masatomo Kuno,Hiroshi Okakura,Satoru Nanno,Mitsutaka Nishimoto,Yasuhiro Nakashima,Hideo Koh,Hirohisa Nakamae,Masayuki Hino
PS-40-4
The safe and effective use of isatuximab in hemodialysisdependent multiple myeloma
Nobuhiro Sogabe,Teruhito Takakuwa,Mitsutaka Nishimoto,Yosuke Makuuchi,Masatomo Kuno,Hiroshi Okamura,Satoru Nanno,Yasuhiro Nakashima,Hideo Koh,Hirohisa Nakamae,Masayuki Hino

 

232回内科学会近畿地方会
WEB 6月26日
ペンブロリズマブ中止4ヶ月後に発症した遅発性免疫関連好中球減少症
仲子聡一郎、中嶋康博、岡村浩史、幕内陽介、久野雅智、高桑輝人、西本光孝、康 秀男、中前博久、日野雅之

 

57回日本補体学会
大阪 9月10日-11日
C-3
移植後早期の補体Ba上昇は移植関連血栓性微小血管症の発症予測マーカーになり得る
岡山裕介、岡村浩史、中前博久、進藤岳郎、大谷克城、日高義彦、大塚泰史、幕内陽介、久野雅智、高桑輝人、原田尚憲、西本光孝、中嶋康博、康 秀男、廣瀬朝生、中前美佳、日野雅之、若宮伸隆、井上徳光

 

115回近畿血液学地方会
WEB 6月5日
12
水頭症を合併した中枢神経原発性リンパ腫(PCNSL)にR−MPV療法と脳室・腹腔(VP)シャントが奏効した一例
田中静大、田添久実代、高桑輝人、岡村浩史、南野 智、西本光孝、中嶋康博、康 秀男、中前博久、日野雅之
54
COVID−19罹患後に自己免疫性溶血性貧血を発症した初発多発性骨錐種の一例
塩見一郎、、中根孝彦、堀内美令、三浦晃子、藤谷洋太郎、山村亮介、佐渡紀克、上田哲也、安井良則

 

43回日本造血細胞移植学会総会
WEB 3月5日・7日
O3-6
悪性リンパ腫に対する強度減弱前処置を用いた臍帯血移植におけるメルファランの用量が予後に与える影響
酒徳一希、金 成元、岡村浩史、内田直之、小林 光、福田隆浩、高山信之、石川 淳、中澤英之、木村貴文、一戸辰夫、熱田由子、近藤英生
O12-2
BNPとNTproBNPは心臓超音波検査より有用な同種造血幹細胞移植後全生存率に対する予後予測因子である
原田尚憲、岡村浩史、中根孝彦、康 史朗、南野 智、西本光孝、廣瀬朝生、中前美佳、中嶋康博、康 秀男、日野雅之、中前博久
P-197
非血縁ドナーコーディネートの検証:COVID-19パンデミック禍での影響
折原勝巳、矢野真吾、日野雅之、吉川亜子、古川久美子、佐藤めぐみ、関 由夏、谷澤魅帆子、中谷邦子、松浦裕子、吉岡亜沙子

P-02
移植看護に対するモチベーションを高める取り組み〜LTFU外来を目指す看護師の育成に向けて〜
西川真紀、大亦由紀、安川千晶、内田桂子、小瀬良仁美、山本千晶、池田真由子、市村由紀乃、鶴田理恵

戻る